AzTrials
AzTrials

Prevention of Dental CariesNCT04032184

Effectiveness of Different Preventive Regimens in Cariogram Parameters and DMF Scores of High Caries Risk Patients: A Randomized Control Trial

A study testing Fluoride toothpaste, fluoride toothpaste and chlorhexidine mouthwash and fluoride toothpaste, chlorhexidine mouthwash, MI varnish in people with Prevention of Dental Caries, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

66 Participants will be divided into three groups according to the tested regimen (A), where (A1) represents participants exposed to fluoride toothpaste, (A2) represents participants exposed to regimen including fluoride toothpaste and chlorhexidine mouthwash and (A3) represents participants exposed to regimen… Read more about this study

Who is it for?
Ages 20 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Prevention of Dental Caries
What is being tested?
Fluoride toothpaste, fluoride toothpaste and chlorhexidine mouthwash and fluoride toothpaste, chlorhexidine mouthwash, MI varnish
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteEgypt
Study dates
1 Oct 2019to 1 Nov 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age range 20-50 years
  • High caries risk patients defined according to cariogram caries risk assessment model
  • On non-cariogenic diet
  • High plaque index
  • Systematically healthy
  • No orthodontic or prosthodontic appliance

Who cannot join

  • Age range less than 20 or more than 50 years
  • Low or moderate caries risk patients according to cariogram
  • Patients with a compromised medical history
  • Cariogenic diet patient
  • Participants with a history of allergy to any of the drugs or chemicals used in the study
  • Patients on any antibiotics during the past month

Trial locations and contacts

1 site in 1 country.

howaida f fouad, Phd contact

00201010008948

howaidafakhry@gmail.com

Esraa A Ahmed, Phd contact

00201020614170

ososdent@hotmail.com

Egypt1 site
  • Howaida Fakhry Fouad

    Giza, Other, 8655

    howaida f fouad, Phd, 00201010008948, howaidafakhry@gmail.com

    Esraa A Ahmed, Phd, 00201020614170, ososdent@hotmail.com

Other trials in Egypt

About this study

66 Participants will be divided into three groups according to the tested regimen (A), where (A1) represents participants exposed to fluoride toothpaste, (A2) represents participants exposed to regimen including fluoride toothpaste and chlorhexidine mouthwash and (A3) represents participants exposed to regimen including fluoride toothpaste, chlorhexidine mouthwash and MI fluoride varnish. The study will be carried over a period of one year, assessment of cariogram will be done in two visits: first visit (baseline: T0) and second visit (after 3 months: T2). In addition assessment of DMF scores will be done in four visits: first visit (baseline: T0), second visit (after 3 months: T1), third visit (after 6 months: T2) and final visit (after 12 months: T3) to obtain the required data

Being tested
Fluoride toothpaste, fluoride toothpaste and chlorhexidine mouthwash, fluoride toothpaste, chlorhexidine mouthwash, MI varnish

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fluoride toothpasteOther

    regimen using fluoride toothpaste

  • fluoride toothpaste and chlorhexidine mouthwashOther

    regimen using fluoride toothpaste and chlorhexidine mouthwash

  • fluoride toothpaste, chlorhexidine mouthwash, MI varnishOther

    regimen using fluoride toothpaste, chlorhexidine mouthwash, MI varnish

Study groups in NCT04032184
Study groupRoleWhat they receive
Fluoride toothpasteActive comparatorNot described
Receives: Other: Fluoride toothpaste
fluoride toothpaste and chlorhexidine mouthwashExperimentalNot described
Receives: Other: fluoride toothpaste and chlorhexidine mouthwash
fluoride toothpaste, chlorhexidine mouthwash, MI varnishExperimentalNot described
Receives: Other: fluoride toothpaste, chlorhexidine mouthwash, MI varnish

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Caries Risk Assessment

    will be evaluated by cariogram

    Measured: an average 3 months

Secondary outcomes (1)
  1. DMF scores

    will be evaluated by ICDAS

    Measured: an average of 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2019
  2. Study start1 Oct 2019 (estimated)
  3. Primary completion1 Oct 2020 (estimated)
  4. Study completion1 Nov 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
66 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04032184
Sponsor's protocol ID
1234567
Status last verified
Jul 2019
First submitted
23 Jul 2019
Last updated
25 Jul 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Fluoride toothpaste, fluoride toothpaste and chlorhexidine mouthwash and fluoride toothpaste, chlorhexidine mouthwash, MI varnish in people with Prevention of Dental Caries, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact howaida f fouad, Phd (00201010008948, howaidafakhry@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Caries Risk Assessment (time frame: an average 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in